<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03477279</url>
  </required_header>
  <id_info>
    <org_study_id>17-0681</org_study_id>
    <secondary_id>R00MH104154</secondary_id>
    <nct_id>NCT03477279</nct_id>
  </id_info>
  <brief_title>Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi</brief_title>
  <official_title>Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi: A Randomized Controlled Trial in Lilongwe</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is promising evidence that couple-based approaches within Malawi's Option B+ prevention
      of mother to child transmission program could address help address 1) poor male engagement in
      the HIV continuum of care, 2) low male adoption of biomedical HIV prevention approaches, 3)
      sub-optimal female engagement in the continuum of care, and 4) poor or uncertain infant
      outcomes. Our team has developed an intervention to address these challenges, and will
      conduct a randomized controlled trial (N=500 couples) to assess intervention effectiveness at
      one year. Women with recent HIV infections enrolled in this trial will be compared against a
      cohort of 350 HIV-uninfected women to explore predictors of HIV acquisition in pregnancy in
      Malawi.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In sub-Saharan Africa, engaging HIV-infected men in HIV care and treatment and engaging
      HIV-uninfected men in prevention has proven challenging. Along all steps of the HIV
      care-seeking cascade, men exhibit worse care-seeking behaviors. They are less likely to seek
      HIV testing and counseling (HTC), initiate combination antiretroviral therapy (cART), and be
      retained in cART care. Poor care-seeking has resulted in a lower prevalence of viral
      suppression and earlier mortality. Additionally, men rarely engage in the antenatal
      care-seeking of their female sexual partners, leading to worse maternal and infant outcomes.
      This low level of engagement has been noted in Malawi's Option B+ prevention of mother to
      child transmission (PMTCT) program, and has been a critical barrier to female Option B+
      uptake and retention, and a missed opportunity for engaging men.

      There is promising evidence that couple-based approaches within Malawi's Option B+ prevention
      of mother to child transmission program could address all of these challenges: poor male
      engagement in the HIV continuum of care, low male adoption of biomedical HIV prevention
      approaches, sub-optimal female engagement in the continuum of care, and poor or uncertain
      infant outcomes. Our team has designed a couples-based intervention to address these
      challenges, and will conduct a randomized controlled trial (N=500 couples) to assess
      intervention effectiveness at one year. Results from this study are expected to inform how
      best to address family outcomes in an Option B+ program.

      This study has the following aims described below:

      Aim 1: Determine whether the couple-based intervention increases new HIV-positive diagnoses
      among HIV-infected male sex partners, helps HIV-infected men engage and remain in care, and
      contributes to male viral suppression compared to individual standard of care. The
      investigators will compare the couple-based intervention to standard of care for increasing
      the proportion of men who are aware of being HIV-infected, the proportion of these men who
      initiate and remain in cART care, and the proportion of these men with viral suppression at
      one year.

      Aim 2: Determine whether the couple-based intervention identifies HIV-discordant couples and
      decreases the likelihood of male exposure to HIV compared to individual standard of care. The
      investigators will compare the intervention to standard of care for increasing the number of
      men with non-HIV exposure from their female partner through consistent condom use, viral
      suppression, abstinence, or a combination of these methods over one year.

      Aim 3: Determine whether the couple-based intervention improves female cART retention and
      viral suppression compared to individual standard of care. The investigators will compare the
      intervention to standard of care for female cART retention and viral suppression at one year.

      Aim 4: Determine whether the couple-based intervention improves infant early infant diagnosis
      uptake compared to individual standard of care. Explore uptake of early infant diagnosis and
      rates of mother-to-child transmission and child survival in the two intervention arms.

      Aim 5: Develop an in-depth understanding of HIV transmission dynamics in Lilongwe. Using the
      biomarkers and behavioral survey, we will seek to understand transmission timing, direction,
      and context in Lilongwe. We will compare women with recent HIV infection to a population of
      HIV-uninfected controls (n=350) to understand predictors of HIV acquisition in pregnancy in
      Malawi.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 25, 2017</start_date>
  <completion_date type="Anticipated">October 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Female viral suppression</measure>
    <time_frame>One year</time_frame>
    <description>The proportion of women with undetectable HIV virus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Male viral suppression</measure>
    <time_frame>One year from female enrollment</time_frame>
    <description>The proportion of HIV infected men in each arm with undetectable HIV virus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Male prevention</measure>
    <time_frame>One year</time_frame>
    <description>The proportion of HIV-uninfected men who report continuous and consistent HIV prevention behaviors</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HIV-free infant survival</measure>
    <time_frame>At the time of early infant diagnosis (approximately 6 weeks after birth)</time_frame>
    <description>The proportion of infants who are alive and HIV-free</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictors of recent HIV infection</measure>
    <time_frame>Baseline</time_frame>
    <description>Risk factor analysis to identify predictors of recent HIV infection among pregnant women</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1850</enrollment>
  <condition>Hiv</condition>
  <arm_group>
    <arm_group_label>Individual (SOC)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>HIV-infected pregnant women enrolled in the individual arm of the study will receive Standard of Care Option B+ procedures.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Couple (Intervention)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to receiving standard of care procedures, HIV-infected pregnant women in the couple arm will be provided with an intervention aimed at recruiting their male partners, providing enhanced couple counseling and testing, engaging their male partners in their care, and supporting male partners to receive care and treatment services.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV-Uninfected Cohort</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>HIV-uninfected pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced Couple HIV Testing and Counseling</intervention_name>
    <description>Participants are provided study-specific partner referral cards and encouraged to bring male partners to antenatal care for a male engagement intervention. Those who do not present on their own are then traced.
Couples will receive three enhanced couple counseling sessions that include: pre-test counseling, return of joint results, and post-test counseling. HIV-infected men will be able to initiate cART at the antenatal clinic and the couple will be offered condoms from the HTC counselor. Between sessions, couple members can pick up condoms and cART for one another.</description>
    <arm_group_label>Couple (Intervention)</arm_group_label>
    <other_name>male engagement intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (HIV-infected Women):

          -  HIV-infected and eligible for Option B+

          -  &gt;18 years old or 15-17 years old and married

          -  Planning to remain in the Bwaila catchment area for the next year or notify the study
             team if they leave the area or change facilities

          -  Part of a heterosexual relationship for &gt;3 months

               -  Expects the partner to be in the relevant catchment area for at least one week in
                  the next six months.

               -  Able and willing to give locator information for this partner

               -  Willing to have study staff conduct phone and physical tracing of that partner

               -  Willing to undergo a couple-based intervention with this partner

          -  Able and willing to provide informed consent

        Inclusion Criteria (Male Partners of HIV-infected women)

          -  &gt;18 years old or 15-17 years old and married

          -  In a relationship with the female partner for &gt;3 months

               -  Willing to undergo a couples-based intervention with their female partner

          -  Able and willing to provide informed consent

        Inclusion Criteria (HIV-uninfected Women):

          -  HIV-uninfected

          -  &gt;18 years old or 15-17 years old and married

          -  Part of a heterosexual relationship for &gt;3 months

               -  Expects the partner to be in the relevant catchment area for at least one week in
                  the next six months.

               -  Willing to receive couples-based HIV testing and counseling with this partner

          -  Able and willing to provide informed consent

        Exclusion Criteria (all Women and Male Partners):

        â€¢ Any condition that in the opinion of the study investigator would compromise the ability
        of the prospective participant to provide informed consent, undergo study procedures
        safely, or would prevent proper conduct of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nora E Rosenberg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bwaila District Hospital Antenatal Unit</name>
      <address>
        <city>Lilongwe</city>
        <state>Central District</state>
        <country>Malawi</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malawi</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 19, 2018</study_first_submitted>
  <study_first_submitted_qc>March 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2018</study_first_posted>
  <last_update_submitted>January 17, 2020</last_update_submitted>
  <last_update_submitted_qc>January 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>couple HIV testing and counseling</keyword>
  <keyword>disclosure</keyword>
  <keyword>Malawi</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

